Glipizide

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Glipizide AND Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of a labeling change for an existing combination drug product; does not contain clinical trial data or efficacy evidence.

MAR 30, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Glipizide (Manufacturing (CMC))

U.S. Food and Drug Administration

FDA supplemental approval for manufacturing changes to an established generic drug; does not contain clinical efficacy or safety data.